The antioxidant tempol prevents and partially reverses dexamethasone- induced hypertension in the rat

American Journal of Hypertension

Volumn 17, Issue 3, 2004, Pages 260-265

  Zhang, Yi ^a   Croft, Kevin D ^b   Mori, Trevor A ^b   Schyvens, Christopher G ^a   McKenzie, Katja U S ^a   Whitworth, Judith A ^a  

^a Biology and Environment   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Dexamethasone; F2 isoprostanes; Hypertension; Oxidative stress; Tempol

Indexed keywords

ANTIOXIDANT; DEXAMETHASONE; DRINKING WATER; GLUCOCORTICOID; ISOPROSTANE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPERTENSION; MALE; NONHUMAN; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; THYMUS;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY WEIGHT; CYCLIC N-OXIDES; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; F2-ISOPROSTANES; GLUCOCORTICOIDS; HYPERTENSION; MALE; MODELS, CARDIOVASCULAR; ORGAN SIZE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE; SPIN LABELS; SYSTOLE; THYMUS GLAND;

EID: 1442348273     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2003.11.004     Document Type: Article

References (29)

1. Scoggins B.A., Spence C.D., Coghlan J.P., Reid A.F., Whitworth J.A. Adrenocortical steroid hypertension a historical perspective. Mantero F., Takeda R., Scoggins B.A., Biglieri E.G., Funder J.W. The Adrenal and Hypertension: From Cloning to Clinic. Serono Symposia. 1989;177-190 Raven Press, New York.
2. Turner S.W., Wen C., Li M., Fraser T.B., Whitworth J.A. Adrenocorticotrophin dose-response relationships in the rat haemodynamic, metabolic and hormonal effects. J Hypertens. 16:1998;593-600.
3. Wen C., Li M., Fraser T., Wang J., Turner S.W., Whitworth J.A. L-arginine partially reverses established adrenocorticotrophin-induced hypertension and nitric oxide deficiency in the rat. Blood Press. 9:2000;298-304.
4. Turner S.W., Wen C., Li M., Whitworth J.A. L-arginine prevents corticotropin-induced increases in blood pressure in the rat. Hypertension. 27:1996;184-189.
5. Li M., Fraser T., Wang J., Whitworth J.A. Dexamethasone-induced hypertension in the rat effects of L-arginine. Clin Exp Pharmacol Physiol. 24:1997;730-732.
6. Vaziri N.D., Ni Z., Oveisi F., Liang K., Pandian R. Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension. 39:2002;135-141.
7. Beswick R.A., Zhang H., Marable D., Catravas J.D., Hill W.D., Webb R.C. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension. 37:2001;781-786.
8. 2α. Hypertension. 33:1999;424-428.
9. 2′ a pulse radiolysis study. Free Radic Biol Med. 19:1995;505-510.
10. Vaziri N.D., Wang X.Q., Oveisi F., Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension. 36:2000;142-146.
11. Cuzzocrea S., McDonald M.C., Mazzon E., Filipe H.M., Centorrino T., Lepore V., Terranova M.L., Ciccolo A., Caputi A.P., Thiemermann C. Beneficial effects of Tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat. Crit Care Med. 29:2001;102-111.
12. Ortiz M.C., Manriquez M.C., Romero J.C., Juncos L.A. Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension. 38:2001;655-659.
13. Zhang Y., Jang R., Mori T.A., Croft K.C., Schyvens C.G., McKenzie K.U.S., Whitworth J.A. The anti-oxidant Tempol reverses and partially prevents adrenocorticotropic hormone-induced hypertension in the rat. J Hypertens. 21:2003;1613-1618.
14. Latta K., Krieg R.J. Jr, Carbajo-Perez E., Carbajo S., Chan J.C. Effects of deflazacort and cortisone on cellular proliferation in the rat thymus. Life Sci. 71:2002;1951-1960.
15. 2-isoprostanes using gas chromatography-mass spectrometry. Anal Biochem. 268:1999;117-125.
16. Nishiyama A., Fukui T., Fujisawa Y., Rahman M., Tian R.X., Kimura S., Abe Y. Systemic and regional hemodynamic responses to Tempol in angiotensin II-infused hypertensive rats. Hypertension. 37:2001;77-83.
17. Maffei A., Poulet R., Vecchione C., Colella S., Fratta L., Frati G., Trimarco V., Trimarco B., Lembo G. Increased basal nitric oxide release despite enhanced free radical production in hypertension. J Hypertens. 20:2002;1135-1142.
18. Kissner R., Nauser T., Bugnon P., Lye P.G., Koppenol W.H. Formation and properties of peroxynitrite as studied by laser flash photolysis, high-pressure stopped-flow technique, and pulse radiolysis. Chem Res Toxicol. 10:1997;1285-1292. (published erratum appears in Chem Res Toxicol 1998;11:557).
19. Lou Y.K., Wen C., Li M., Adams D.J., Wang M.X., Yang F., Morris B.J., Whitworth J.A. Decreased renal expression of nitric oxide synthase isoforms in adrenocorticotropin-induced and corticosterone-induced hypertension. Hypertension. 37:2001;1164-1170.
20. Radomski M.W., Palmer R.M., Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA. 87:1990;10043-10047.
21. Simmons W.W., Ungureanu-Longrois D., Smith G.K., Smith T.W., Kelly R.A. Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport. J Biol Chem. 271:1996;23928-23937.
22. Roberts L.J., Morrow J.D. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med. 28:2000;505-513.
23. Suzuki H., Swei A., Zweifach B.W., Schmid-Schonbein G.W. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hydroethidine microfluorography. Hypertension. 25:1995;1083-1089.
24. Iuchi T., Akaike M., Mitsui T., Ohshima Y., Shintani Y., Azuma H., Matsumoto T. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res. 92:2003;81-87.
25. Hoagland K.M., Maier K.G., Roman R.J. Contribution of 20-HETE to the anti-hypertensive effect of Tempol in Dahl salt-sensitive rats. Hypertension. 41:2003;697-702.
26. Dobrian A.D., Schriver S.D., Prewitt R.L. Role of angiotensin II and free radicals in blood pressure regulation in a rat model of renal hypertension. Hypertension. 38:2001;361-366.
27. Xu H., Fink G.D., Galligan J.J. Nitric oxide-independent effects of Tempol on sympathetic nerve activity and blood pressure in DOCA-salt rats. Am J Physiol Heart Circ Physiol. 283:2002;H885-H892.
28. Dodt C., Keyser B., Molle M., Fehm H.L., Elam M. Acute suppression of muscle sympathetic nerve activity by hydrocortisone in humans. Hypertension. 35:2000;758-763.
29. Kumar N., Shan L.X., Hardy M.P., Bardin C.W., Sundaram K. Mechanism of androgen-induced thymolysis in rats. Endocrinology. 136:1995;4887-4893.